5/10/2025

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Teleflex Incorporated resulting from allegations that...

Source: Finnhub

5/8/2025

Teleflex Incorporated's ( NYSE:TFX ) earnings announcement last week didn't impress shareholders. However, our analysis...

Source: Yahoo

5/7/2025

LOS ANGELES, May 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Teleflex Incorporated ...

Source: Finnhub

5/7/2025

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Teleflex (NYSE:TFX) and its peers.

Source: Yahoo

5/7/2025

Let’s dig into the relative performance of LeMaitre (NASDAQ:LMAT) and its peers as we unravel the now-completed Q1 surgical equipment & consumables - specialty earnings season.

Source: Yahoo

5/5/2025

TFX benefits from a diversified product portfolio in the first quarter of 2025, with strength in the Surgical and Interventional segments.

Source: Yahoo

5/4/2025

Last week, you might have seen that Teleflex Incorporated ( NYSE:TFX ) released its quarterly result to the market. The...

Source: Yahoo

5/2/2025

Teleflex (NYSE:TFX) has had a rough three months with its share price down 30%. It seems that the market might have...

Source: Yahoo

5/2/2025

Despite a revenue decline, Teleflex Inc (TFX) focuses on strategic initiatives and market expansion to drive future growth.

Source: Yahoo

5/2/2025

Q1 2025 Teleflex Inc Earnings Call

Source: Yahoo

5/1/2025

NEW YORK, May 1, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor...

Source: Finnhub

5/1/2025

Teleflex Incorporated (NYSE:TFX) Q1 2025 Results Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsLawrence Keusch - VP-IR & Strategy...

Source: SeekingAlpha

5/1/2025

Medical technology company Teleflex (NYSE:TFX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 5% year on year to $700.7 million. Its non-GAAP profit of $2.91 per share was 0.9% above analysts’ consensus estimates.

Source: Yahoo

5/1/2025

While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Source: Yahoo

5/1/2025

Teleflex (TFX) delivered earnings and revenue surprises of 1.04% and 0.22%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Source: Yahoo

5/1/2025

On a per-share basis, the Wayne, Pennsylvania-based company said it had profit of $2.07. Earnings, adjusted for one-time gains and costs, came to $2.91 per share. The results surpassed Wall Street expectations.

Source: Yahoo

5/1/2025

WAYNE, Pa., May 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 30, 2025. First quarter financial summary Revenues of $700.7 million, down 5.0% compared to the prior year period; down 3.8% on an adjusted constant currency basis GAAP diluted EPS from continuing operations of $2.07, compared to $0.33 in the prior year period Adjusted diluted EPS from continuing operations of $2.91, compared to $3.21

Source: Yahoo

5/1/2025

7 H O H I O H [ , Q F R U S R U D W H G ) L U V 4 WX D U W H U ( D U Q L Q J V & R Q I H U H Q F H & D O O ...

Source: Finnhub

4/30/2025

WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX), will be presenting at the BofA Securities 2025 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Wednesday, May 14, 2025, at 1:40 p.m. (PT). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex IncorporatedAs a global provider of medical technologies, Teleflex is driven by our purpose to

Source: Yahoo

4/30/2025

WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an expansion to the Indications for Use of the QuikClot Control+™ Hemostatic Device to include all grades of internal and external bleeding. The QuikClot Control+™ Device was previously indicated for temporary control of class III and class IV internal organ space bleeding, severely bleedin

Source: Yahoo